Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Gary E. Raskob, Ph.D., Nick van Es, M.D., Peter Verhamme, M.D., Marc Carrier, M.D., Marcello Di Nisio, M.D., David Garcia, M.D., Michael A. Grosso, M.D., Ajay K. Kakkar, M.B., B.S., Michael J. Kovacs, M.D., Michele F. Mercuri, M.D., Guy Meyer, M.D., Annelise Segers, M.D.,
Minggao Shi, Ph.D., Tzu‑Fei Wang, M.D., Erik Yeo, M.D., George Zhang, Ph.D., Jeffrey I. Zwicker, M.D., Jeffrey I. Weitz, M.D., and Harry R. Büller, M.D., for the Hokusai VTE Cancer Investigators.

N Engl J Med 2018;378:615-24.     DOI: 10.1056/NEJMoa1711948

Scarica l’articolo

Liberamente tratto dal sito web:   https://www.researchgate.net/publication/321764667_Edoxaban_for_the_Treatment_of_Cancer-Associated_Venous_Thromboembolism

2015 © Copyright - AMGe